Systemic therapy for organ preservation - report from ESMO2024

Professor David Sebag-Montefiore shares his thoughts on systemic therapy for organ preservation and the findings from the NO-CUT trial were presented at the ESMO Congress 2024. The study explored the efficacy of more aggressive initial treatment known as total neoadjuvant therapy followed by non-operative management in patients with mismatch repair proficient locally advanced rectal cancer. Video: https://medicaldigest.org/scientific-contents/interview:systemic-therapy-organ-preservation